ストックスクリーナーアプリを入手
336.23
4.22%
-14.80
アフターアワーズ：
336.23
Madrigal Pharmaceuticals Inc (MDGL) 最新ニュース
Madrigal Pharmaceuticals to Present at 45th Annual TD Cowen Health Care Conference - MyChesCo
Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference - The Manila Times
Can Madrigal's TD Cowen Conference Reveal Signal Major Clinical Progress? - StockTitan
Madrigal Pharmaceuticals (MDGL) to Release Quarterly Earnings on Wednesday - MarketBeat
Is Madrigal Pharmaceuticals (NASDAQ:MDGL) Using Debt Sensibly? - Simply Wall St
Kornitzer Capital Management Inc. KS Invests $4.55 Million in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
Madrigal Pharmaceuticals' SWOT analysis: rezdiffra sales fuel stock's growth potential - Investing.com Nigeria
Madrigal Pharmaceuticals Reports Q2 2024 Financial Results and Provides Updates - MSN
(MDGL) Investment Report - Stock Traders Daily
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Shares Sold by Fiera Capital Corp - MarketBeat
Madrigal Pharmaceuticals to Announce Q4 and Full-Year 2024 Results with Live Webcast - MSN
What is Leerink Partnrs' Estimate for MDGL FY2024 Earnings? - MarketBeat
Newbridge Financial Services Group Inc. Takes $1.30 Million Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
Madrigal Pharmaceuticals to Release Fourth-Quarter and Full-Year 2024 Financial Results and Host Webcast on February 26, 2025 - The Manila Times
Madrigal Pharmaceuticals to Release Fourth-Quarter and Full-Year 2024 Financial Results and Host Webcast on - EIN News
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Shares Sold by Mirae Asset Global Investments Co. Ltd. - MarketBeat
(MDGL) Long Term Investment Analysis - Stock Traders Daily
Rheos Capital Works Inc. Cuts Stock Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
Prediction: This Pharma Stock Will Be the Best Performer in 2025 - 24/7 Wall St.
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
This Stock Just Doubled in 1 Day -- Is It Still a Buy? - The Motley Fool
Madrigal Pharmaceuticals CEO sells shares worth $531,020 - MSN
(01/29/25) Top Picks 2025: Madrigal Pharmaceuticals (MDGL) - Moneyshow.com
Madrigal Pharmaceuticals CEO sells shares worth $531,020 By Investing.com - Investing.com Australia
Madrigal Pharmaceuticals executive sells shares worth $34,529 - MSN
Madrigal Pharmaceuticals chief commercial officer sells $116,328 in stock - MSN
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Insider Carole Huntsman Sells 347 Shares - MarketBeat
Insider Selling: Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) CEO Sells 1,584 Shares of Stock - MarketBeat
Insider Selling: Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) CMO Sells 648 Shares of Stock - MarketBeat
Insider Selling: Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) VP Sells 103 Shares of Stock - MarketBeat
Madrigal Pharmaceuticals chief commercial officer sells $116,328 in stock By Investing.com - Investing.com South Africa
Madrigal Pharmaceuticals executive sells shares worth $34,529 By Investing.com - Investing.com Canada
(MDGL) Trading Advice - Stock Traders Daily
Madrigal Pharmaceuticals (MDGL) Stock Price, News & Analysis - MarketBeat
Exploring Three High Growth Tech Stocks in the United States - Yahoo Finance
Brokers Issue Forecasts for MDGL FY2025 Earnings - MarketBeat
Cantor Fitzgerald Estimates MDGL FY2025 Earnings - Defense World
MDGL (Madrigal Pharmaceuticals) Long-Term Debt & Capital Le - GuruFocus.com
Cantor Fitzgerald Predicts MDGL FY2025 Earnings - MarketBeat
MDGL (Madrigal Pharmaceuticals) Dividends per Share : $0.00 (TTM As of Sep. 2024) - GuruFocus.com
Madrigal Pharmaceuticals’ Treatment Could Be a Blockbuster in the Making - TipRanks
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):